姓名：尉驍性別： 男 政治面貌：中共黨員學(xué)歷：研究生學(xué)位： 博士 職稱：中級(jí)

博、碩導(dǎo)師：碩導(dǎo)本崗位工作年數(shù)：5

研究方向：

塵肺病合并感染細(xì)菌流行病學(xué)研究，細(xì)菌碳青霉烯耐藥機(jī)制，呼吸道菌群在肺部疾病中的作用

榮譽(yù)稱號(hào)：

2024年度山西醫(yī)科大學(xué)第一醫(yī)院“優(yōu)秀青年”

學(xué)術(shù)任職：

山西省醫(yī)師協(xié)會(huì)免疫微生態(tài)專業(yè)委員會(huì)常務(wù)委員

山西省醫(yī)學(xué)科呼吸病學(xué)分會(huì)感染學(xué)組委員

近五年承擔(dān)科研課題情況：

(1)國(guó)家自然科學(xué)基金委員會(huì)青年科學(xué)基金項(xiàng)目，miyX基因通過LuxS/AI-2群體感應(yīng)系統(tǒng)提高解鳥氨酸拉烏爾菌碳青霉烯耐藥流行克隆菌株質(zhì)粒接合效率的機(jī)制研究，82202569

(2)山西省基礎(chǔ)研究計(jì)劃，Al-2合成酶LuxS及其甲基化修飾在肺炎克雷伯持留菌中的作用及其機(jī)制研究，20210302124635

(3)山西省衛(wèi)生健康委科研課題，塵肺病患者肺部韋榮球菌代謝物L(fēng)-酪氨酸加重氣道炎癥降低肺通氣功能的機(jī)制研究，2024067

代表性論著及近五年的代表性論文（限10項(xiàng)以內(nèi)）：

（1）Jingfen Zhang , Qiaoyu Li , Jingjing Liu , Fangfang Fan , Yiwei Shi,Xiao YuPrevalence of Hypervirulent Klebsiella pneumoniae Strains inCOVlD-19 Patients with Bacterial Co-infections, 2025, Front. Microbiol. 16:1535893.doi: 10.3389/fmicb.2025.1535893

（2）Xiao Yu,Tao Xiong, Lu Yu, Gaisheng Liu, Fan Yang, Xueqin Li, Yangyang Wei, Xiaojing Wang, Shuting Wei, Yi Jiang, Xiaomei Kong, Shouan Ren, Yiwei Shi. Gut microbiome and metabolome profiling in coal workers' pneumoconiosis: potential links to pulmonary function. Microbiology spectrum. 2024 Sep 16:e0004924. doi: 10.1128/spectrum.00049-24. Epub ahead of print. PMID: 39283109.

（3）Zhan Qing, Teng Gaoqin, Chen Weiwei,Yu Xiao.High prevalence of ST5-SCCmec II-t311 clone of methicillin-resistantStaphylococcus aureusisolated from bloodstream infections in East China. BMC Microbiology. 2024 Mar 16;24(1):89. doi: 10.1186/s12866-024-03232-5. PMID: 38491414; PMCID: PMC10943896.

（4）Lu Hong, Cheng Li, Cui Shu, Yi Xin, Li Xueqin, Liu Xiang, Kong Xiaomei,Yu Xiao. Characterizing the Loss and Acquisition of Tn2-like Transposon in Klebsiella pneumoniae: Implications for Carbapemase Gene Dissemination.Journal of Global Antimicrobial Resistance. 2024 May 6:38, 98–102. doi: 10.1016/j.jgar.2024.04.011. Epub ahead of print. PMID: 38719187.

（5）Xiao Yu, Li Cheng, Xin Yi, Bing Li, Xueqin Li, Xiang Liu, Zhihong Liu, Xiaomei Kong. Gut phageome: challenges in research and impact on human microbiota. Frontiers in Microbiology. 2024 Mar 22;15:1379382. doi: 10.3389/fmicb.2024.1379382. PMID: 38585689; PMCID: PMC10995246.

（6）Yi Xin, Lu Hong, Liu Xiang, He Junyi, Li Bing, Wang Zhelong, Zhao Yujing, Zhang Xinri,Yu Xiao. Unravelling the enigma of the human microbiome: Evolution and selection of sequencing technologies. Microbial Biotechnology. 2024 Jan;17(1):e14364. doi: 10.1111/1751-7915.14364. Epub 2023 Nov 6. PMID: 37929823; PMCID: PMC10832515.

（7）Zhang Chenwei, Xi Yujia, Zhang Yukai, He Peiyun, Su Xuesen, Li Yishan, Zhang Mengyuan, Liu Haizhao,Yu Xiao, Shi Yiwei. Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study. Heart Lung. 2024 Mar-Apr;64:189-197. doi: 10.1016/j.hrtlng.2024.01.002. Epub 2024 Jan 29. PMID: 38290183.

（8）Yu Xiao; Jin Ye; Zhou Wangxiao; Xiao Tingting; Wu Zhongwen; Su Junwei; Gao Hainv; Shen Ping; Zheng Beiwen; Luo Qixia; Li lanjuan; Xiao Yonghong ; Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome，F(xiàn)rontiers in Cellular and Infection Microbiology，2022，11(76)

（9）Yu Xiao; Zheng Beiwen; Xiao，F(xiàn)eng; Jin Ye; Guo Lihua; Xu Hao; Luo Qixia; Xiao Yonghong ; Effect of Short-Term Antimicrobial Therapy on the Tolerance and Antibiotic Resistance of Multidrug-Resistant Staphylococcus capitis，Infection and Drug Resistance，2020，13: 2017-2026

（10）Yu Xiao;Zheng Beiwen; Zhang Jing; Xu Hao; Xiao Tingting; Zhou Yanzi; Zhang Shunti an; Zhu Yunying; Wang Yuan; Xiao Yonghong ; Comprehensive Genome Analysis of Carbapenem-Resist ant Strains of Raoultella Species，an Emerging Multidrug-Resistant Bacterium in Hospitals，Antimicrobial Agents and Chemotherapy，2019，63(12): e01367-19